Hematological Responses in COVID-19 Patients
Summary
Infection with SARS-CoV-2 precipitates a spectrum of alterations in blood cell populations and haematological indices that correlate closely with disease severity and prognosis. Common features include lymphopenia and neutrophilia, reflecting dysregulated innate and adaptive immunity, alongside coagulopathies marked by elevated D-dimer levels and hyperviscosity. Morphological and phenotypic changes in monocytes and neutrophils—such as increased monocyte size and activation profiles—contribute to a pro-inflammatory milieu. Red blood cell parameters also shift: increased red cell distribution width and aberrant haemoglobin and iron metabolism have been linked to hypoxia and thrombotic risk. Together, these haematological signatures support risk stratification, inform clinical management and suggest mechanistic targets for intervention.
Research from Nature Portfolio
Monocyte distribution width (MDW), a cytometric parameter denoting variation in monocyte size and activation, has emerged as an early biomarker of severe COVID-19. In a longitudinal cohort, elevated MDW correlated strongly with conventional inflammatory markers (C-reactive protein, ferritin) and predicted fatal outcome with robust sensitivity and specificity. This finding underlines the value of routine cytometric indices in guiding prognostication and may inform early therapeutic decisions.
Hematological Responses in COVID-19 Patients publication trend
The graph below shows the total number of articles in hematological responses in covid-19 patients across all publications each year (not limited to Nature Index journals).
Technical terms
Lymphopenia: A reduction in the absolute lymphocyte count often observed in severe COVID-19, indicating compromised adaptive immunity.
Neutrophilia: An increase in neutrophil count reflecting heightened innate immune activation and inflammation.
Monocyte Distribution Width (MDW): A flow cytometric measure of variability in monocyte size, serving as an indicator of monocyte activation status.
Red Cell Distribution Width (RDW): A measure of variation in red blood cell volume, with elevated values linked to hypoxia and inflammation.
Eryptosis: Programmed death of erythrocytes characterised by cell shrinkage and membrane blebbing, contributing to anaemia and thrombosis in COVID-19.
References
- Blood matters: the hematological signatures of Coronavirus infection. Cell Death & Disease (2024).
- Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up. BMC Medicine (2024).
- Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics. International Journal of Biological Macromolecules (2023).
- Accumulation of oxysterols in the erythrocytes of COVID-19 patients as a biomarker for case severity. Respiratory Research (2023).
- Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. Journal of Leukocyte Biology (2020).
- Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Scientific Reports (2021).
- SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism. Stem Cell Reviews and Reports (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.